Vaccination strategies for patients under monoclonal antibody and other biological treatments: an updated comprehensive review based on EMA authorizations to January 2024-Reference-Cited by-同舟云学术

Vaccination strategies for patients under monoclonal antibody and other biological treatments: an updated comprehensive review based on EMA authorizations to January 2024

Published:2024-09-11 Issue: Volume: Page:
ISSN:1476-0584
Container-title:Expert Review of Vaccines
language:en
Short-container-title:Expert Review of Vaccines

Author:

Rivera-Izquierdo Mario¹²³⁴^ORCID,Morales-Portillo Arturo⁵⁶,Guerrero-Fernández de Alba Inmaculada¹,Fernández-Martínez Nicolás Francisco³⁴⁷^ORCID,Schoenenberger-Arnaiz Joan Antoni⁵⁶,Barranco-Quintana José Luis⁸⁹¹⁰^ORCID,Valero-Ubierna Carmen¹

Affiliation:

1. Service of Preventive Medicine and Public Health, Hospital Universitario San Cecilio, Granada, Spain

2. Department of Preventive Medicine and Public Health, University of Granada, Granada, Spain

3. Instituto de investigación biosanitaria de Granada (ibs.GRANADA), Granada, Spain

4. CIBER de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain

5. Service of Pharmacy, Hospital Universitario Arnau de Vilanova, Lleida, Spain

6. Pharmacoepidemiology and Pharmacodynamics Group, Instituto de investigación biomédica de Lleida (IRBLleida), Lleida, Spain

7. Andalusian School of Public Health (EASP), Granada, Spain

8. Service of Preventive Medicine and Public Health, Hospital Universitario Reina Sofía, Spain

9. Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Spain

10. Expert Committee on Andalusian Vaccine Plan, Consejería de Salud y Familias, Junta de Andalucía, Sevilla, Spain

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/14760584.2024.2401839

Reference125 articles.

1. The pharmacology and therapeutic applications of monoclonal antibodies

2. Developments in therapy with monoclonal antibodies and related proteins

3. Monoclonal antibody therapeutics: history and future

4. Monoclonal antibodies — a proven and rapidly expanding therapeutic modality for human diseases

5. European Medicines Agency (EMA). European Public Assessment Report. https://www.ema.europa.eu/en/glossary/european-public-assessment-report. Accessed on January 1 2024. ** Official website of the European Medicines Agency. Data on mAbs regarding authorization marketing and technical datasheets have been checked on this website.